Memantine and Exercise to Improve Cognitive Function and Modulate Biological Pathways of Cognitive Decline During Chemotherapy in Breast Cancer

Clinical trial NCT06727773 · RECRUITING

Trial details

NCT number: NCT06727773
Sponsor: UNC Lineberger Comprehensive Cancer Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Locally Advanced Breast Cancer Cognitive Impairment Cognitive Decline Cognitive Change Breast Cancer Stage I Breast Cancer Stage II Breast Cancer Stage III

Start date: 2025-08-19
Primary completion: 2029-06-15
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.